ABIVAX Société Anonyme (ABVX) - Latest Market Data

Price & Market Data

Price: $121.8

Daily Change: -$0.29 / 0.24%

Daily Range: $120.5 - $124.2

Market Cap: $9,625,156,608

Daily Volume: 734,229

Performance Metrics

1 Week: -1.93%

1 Month: 0.07%

3 Months: 1.85%

6 Months: 15.31%

1 Year: 1,797%

YTD: -9.98%

About ABIVAX Société Anonyme (ABVX)

Explore the fundamentals of ABIVAX Société Anonyme (ABVX). The stock is at 121.8, exhibiting a daily change of -$0.29 / 0.24%. Its market capitalization is 9,625,156,608. Performance metrics cover YTD and all monthly and weekly periods.

Company Details

Employees: 69

Sector: Health technology

Industry: Pharmaceuticals: other

Country: France

Details

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Selected stocks

Lucid Group, Inc. (LCID)

ProPetro Holding Corp. (PUMP)

United Fire Group, Inc (UFCS)

Ascendis Pharma A/S (ASND)